Masanori Ito Selected Research

Pepsinogen A (Pepsinogen)

1/2022	Serum Gastrin and Pepsinogen Levels after Administration of Acid Secretion Inhibitors for Ulcers due to Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer.
4/2019	Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection.
9/2017	Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
1/2017	Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.
10/2015	Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
2/2014	Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
9/2011	Helicobacter pylori cagA polymorphism and gastric inflammation: an international comparison between Japanese and Brazilian patients.
6/2007	Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.
4/2007	Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
9/2006	Helicobacter pylori infection is the major risk factor for gastric inflammation in the cardia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanori Ito Research Topics

Disease

34	Neoplasms (Cancer) 01/2021 - 07/2002
28	Stomach Neoplasms (Stomach Cancer) 06/2022 - 05/2002
19	Infections 07/2022 - 01/2003
15	Gastritis 06/2022 - 07/2002
9	Inflammation (Inflammations) 04/2020 - 01/2005
8	Carcinoma (Carcinomatosis) 11/2012 - 10/2003
7	Atrophy 03/2020 - 01/2006
6	COVID-19 10/2022 - 01/2021
5	Hemorrhage 01/2020 - 08/2010
5	Hypoxia (Hypoxemia) 12/2018 - 06/2003
5	Atrophic Gastritis 09/2017 - 04/2007
5	Carcinogenesis 11/2012 - 08/2003
4	Ulcer 01/2022 - 04/2006
4	Metaplasia 09/2013 - 01/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2007 - 06/2003
3	Pneumonia (Pneumonitis) 10/2022 - 07/2020
3	Pain (Aches) 08/2017 - 05/2011
3	Proteinuria 01/2017 - 12/2009
3	Myocardial Infarction 03/2016 - 03/2015
3	Obesity 06/2015 - 10/2008
3	Gastroesophageal Reflux (GERD) 03/2013 - 09/2006
3	Duodenal Ulcer (Curling's Ulcer) 12/2010 - 04/2003
2	Communicable Diseases (Infectious Diseases) 07/2022 - 01/2021
2	Wounds and Injuries (Trauma) 03/2022 - 08/2009
2	Hyperalgesia 01/2022 - 01/2012
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2012
2	Pathologic Constriction (Stenosis) 01/2021 - 07/2009
2	Diarrhea 01/2021 - 12/2009
2	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 02/2013
2	Fibrosis (Cirrhosis) 12/2020 - 02/2015
2	Cysts 04/2020 - 04/2002
2	Necrosis 01/2020 - 05/2016
2	Seizures (Absence Seizure) 12/2017 - 06/2015
2	Walker-Warburg Syndrome 08/2017 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2015
2	Non-Erosive Reflux Disease 03/2013 - 05/2012
2	Peptic Esophagitis (Reflux Esophagitis) 03/2013 - 05/2009
2	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2012 - 02/2011
2	Trigeminal Neuralgia (Tic Douloureux) 05/2012 - 03/2009
2	Peptic Ulcer (Peptic Ulcers) 12/2010 - 08/2010
2	Crohn Disease (Crohn's Disease) 12/2009 - 01/2005
2	Microsatellite Instability 06/2009 - 11/2003

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 06/2022 - 07/2002
13	Pepsinogen A (Pepsinogen)IBA 01/2022 - 05/2002
9	GastrinsIBA 01/2022 - 04/2003
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2005
7	Biological ProductsIBA 07/2022 - 01/2006
6	Proton Pump InhibitorsIBA 06/2022 - 05/2009
5	AcidsIBA 01/2022 - 09/2006
5	Pharmaceutical PreparationsIBA 01/2021 - 07/2008
5	InterleukinsIBA 01/2020 - 11/2003
5	AdipokinesIBA 01/2017 - 01/2014
5	CytokinesIBA 03/2016 - 03/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2004 - 06/2003
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 08/2010
4	AntibodiesIBA 01/2021 - 01/2003
4	Bile Acids and Salts (Bile Acids)IBA 12/2020 - 09/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 04/2009
3	Capsules (Microcapsules)IBA 01/2017 - 06/2007
3	Messenger RNA (mRNA)IBA 05/2016 - 06/2003
3	ParaffinIBA 12/2010 - 06/2003
3	AntigensIBA 01/2009 - 01/2004
2	Interferon Type IIBA 10/2022 - 03/2022
2	AutoantibodiesIBA 10/2022 - 03/2022
2	bu-zhong-yi-qi-tangIBA 07/2022 - 01/2021
2	kakkon-toIBA 07/2022 - 01/2021
2	kamikihi-to (KKT)IBA 07/2022 - 01/2021
2	Celecoxib (Celebrex)FDA Link 01/2021 - 02/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 08/2010
2	Conditioned Culture MediaIBA 12/2020 - 11/2003
2	C-Reactive ProteinIBA 04/2020 - 12/2009
2	Urea (Carbamide)FDA LinkGeneric 03/2020 - 04/2003
2	AntralIBA 03/2020 - 05/2006
2	LipopolysaccharidesIBA 01/2020 - 03/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017 - 02/2011
2	Interleukin-6 (Interleukin 6)IBA 05/2016 - 03/2005
2	FollistatinIBA 01/2016 - 07/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2015 - 12/2009
2	Neurofibromin 1 (Neurofibromin)IBA 01/2015 - 01/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 05/2013 - 01/2007
2	Hematoxylin (Haematoxylon)IBA 05/2013 - 01/2007
2	Cholecystokinin B ReceptorIBA 03/2013 - 01/2008
2	SteroidsIBA 01/2013 - 02/2011
2	GadoliniumIBA 01/2013 - 04/2009
2	Advanced Glycation End ProductsIBA 12/2011 - 10/2008
2	Tyrosine (L-Tyrosine)FDA Link 01/2010 - 01/2009
2	Infliximab (Remicade)FDA Link 12/2009 - 01/2005

Therapy/Procedure

28	Therapeutics 06/2022 - 01/2003
3	Kampo Medicine (Kampo) 07/2022 - 01/2021
3	Conservative Treatment 01/2021 - 12/2006
3	Craniotomy 02/2011 - 09/2008
2	Liver Transplantation 10/2022 - 10/2012
2	Gastrectomy 06/2022 - 05/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 07/2011
2	Endoscopes 04/2020 - 05/2011
2	Endoscopic Hemostasis 01/2020 - 01/2012
2	Induced Hyperthermia (Thermotherapy) 12/2017 - 06/2015
2	Ligation 03/2015 - 01/2012
2	Microvascular Decompression Surgery 05/2012 - 03/2009